When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Zynex (NASDAQ:ZYXI) has reported prelim Q1 revenues of $30.5M to $31.5M (consensus: $32.33M) and adj. EBITDA of $3M - $4M. The revenue estimate is ~26% higher than Q121 and adjusted EBITDA is estimated to increase ~900% Y/Y. The pain management division saw Q1 order growth of 3% Y/Y. March 2022 reflected the highest number of orders in the company's history. The medical technology firm reiterated its FY22 guidance of $150M to $170M (consensus: $162.82M) in revenue and adj. EBITDA between $25M and $35M.